AFP Test (Alpha-Fetoprotein Blood Test): Uses, Limits and What Your Report Means

Key takeaways

• AFP is a marker, not a verdict. A raised AFP does not confirm cancer, and a normal AFP does not exclude it.
• AFP is used in two very different settings: oncology/liver surveillance in adults, and prenatal screening in pregnancy. The interpretation rules are not interchangeable.
• Many hepatocellular carcinomas produce little or no AFP, so liver cancer surveillance relies on ultrasound, with AFP as an adjunct.
• Hepatitis, cirrhosis, pregnancy and liver regeneration can all raise AFP without cancer being present.
• In pregnancy, AFP screening only estimates risk. Confirmation needs detailed ultrasound and, where indicated, diagnostic testing.

At a glance

Also known as

• Alpha-fetoprotein test, a-fetoprotein, alfa feto protein
• AFP tumour marker, serum AFP
• AFP blood test, "liver cancer marker test" (commonly used but imprecise)
• MSAFP, maternal serum AFP, when done in pregnancy
• Often ordered together with "LFT" (SGPT/SGOT, i.e. ALT/AST) and a USG abdomen (sonography) in liver clinics

What the AFP test is

Alpha-fetoprotein is a protein made in large amounts by the fetal liver and yolk sac. Levels fall sharply after birth and remain low through adult life. Certain tumours, particularly hepatocellular carcinoma and some germ cell tumours, can start producing AFP again, which is why the AFP test is used as a tumour marker.

In pregnancy, AFP crosses into the mother's blood. The maternal serum AFP concentration changes week by week, so results in pregnancy are reported against gestational age, usually as a multiple of the median (MoM) rather than as a plain number.

The AFP test is a laboratory immunoassay. Different laboratories use different analysers and assay kits, so values are not always directly comparable between labs. For monitoring over time, using the same laboratory is preferable.

Why the AFP test is done

• Liver cancer surveillance: in people with cirrhosis or chronic hepatitis B or C, AFP may be used alongside six-monthly abdominal ultrasound.
• Assessment of a liver lesion: AFP adds information when a mass is found on imaging, but does not replace imaging or biopsy.
• Germ cell tumours: AFP, along with beta-hCG and LDH, helps classify testicular and ovarian germ cell tumours, guide staging and risk grouping, and monitor treatment response.
• Treatment monitoring and recurrence: a falling AFP after surgery or chemotherapy suggests response; a rising AFP prompts re-evaluation.
• Prenatal screening: as part of a multiple-marker second-trimester screen for open neural tube defects, abdominal wall defects and some chromosomal conditions.

Who should get this test

• Adults with cirrhosis of any cause, or chronic hepatitis B or C, enrolled in a liver cancer surveillance programme, usually with ultrasound, at the interval their hepatologist advises.
• People with a newly found liver mass on ultrasound or CT.
• Men with a testicular lump or swelling, as part of tumour marker testing before and after treatment.
• People with a suspected ovarian or extragonadal germ cell tumour, including young women with a rapidly growing pelvic mass.
• Anyone on treatment or follow-up for an AFP-producing tumour.
• Pregnant women offered second-trimester serum screening, particularly where first-trimester screening was not done.

The AFP test is not a general health check-up test. Used as a standalone cancer screen in people with no risk factors and no symptoms, it produces far more false alarms and false reassurance than useful information. Discuss with your doctor before adding it to a wellness panel.

What the AFP test cannot detect or exclude

• The AFP test cannot diagnose cancer. It measures one protein. Diagnosis needs imaging, and often tissue or cytology.
• A normal AFP does not exclude hepatocellular carcinoma. A substantial proportion of liver cancers, including many small early tumours, do not raise AFP. This is why ultrasound remains the backbone of surveillance.
• A normal AFP does not exclude a germ cell tumour. Pure seminomas and pure dysgerminomas typically do not produce AFP. Choriocarcinoma raises hCG rather than AFP.
• AFP does not tell you where a tumour is, how large it is, or whether it has spread. Only imaging can address that.
• AFP is not a test of liver function. It says nothing about bilirubin, albumin, clotting or fibrosis stage.
• In pregnancy, AFP screening cannot diagnose anything. It cannot exclude Down syndrome, cannot exclude a neural tube defect (closed defects usually do not raise AFP), and does not assess most other birth differences.
• A negative AFP result means AFP was not raised in that sample: not that disease has been excluded. If symptoms continue despite a normal result, return to your doctor for review rather than assuming all is well.

Related but different examinations

The AFP test and prenatal AFP screening are not the same examination in practice, even though both measure the same protein. Reference frameworks, reporting units and follow-up pathways differ entirely.

How to prepare

Preparation is set by the collecting laboratory and by the doctor who requested the test. Where instructions differ, your own unit's instructions take precedence.

• Fasting: usually not needed for AFP alone. If AFP is bundled with fasting tests such as glucose or lipids, the fasting rule for those applies.
• Medicines and supplements: bring a current list, including AYUSH preparations, herbal products and gym or bodybuilding supplements, since these can be associated with liver injury and altered liver tests. Do not stop or change any prescribed medicine for this test, speak to the prescriber first.
• Previous reports: carry earlier AFP values, ultrasound or CT reports, and hepatitis B or C status. Trend matters more than a single figure.
• Same laboratory where possible for serial monitoring.
• Biotin supplements in high dose can interfere with some immunoassays; mention them.

If you are pregnant

Second-trimester serum screening is time-sensitive and usually offered around 15-20 weeks. Accurate gestational dating, ideally confirmed by an early ultrasound, is essential, wrong dates are one of the commonest reasons for a falsely abnormal result. Your weight, number of fetuses, diabetes status and ethnicity are used in risk calculation, so give this information accurately.

If you have diabetes on glucose-lowering treatment

If your appointment has been combined with fasting tests, discuss timing of insulin or tablets with your prescriber beforehand to avoid hypoglycaemia. Carry a fast-acting sugar source.

If you have chronic kidney disease, heart failure or a fluid restriction

No fluid loading is required for an AFP blood test. Do not increase your fluid intake for this test if you have been given a fluid restriction.

Children

AFP is naturally high in newborns and falls over the first months of life, so paediatric results must be read against age-appropriate expectations by a paediatrician or paediatric oncologist. Paediatric blood sampling uses smaller volumes and topical anaesthetic where available.

Older adults

Veins can be more fragile; bruising is more common. Mention blood thinners so the staff can apply pressure for longer.

What happens during the AFP test

• Registration and consent for the requested test.
• Blood draw: a tourniquet is applied, the skin is cleaned, and a few millilitres of blood are collected from an arm vein. This part usually takes 2-5 minutes.
• After the draw: pressure is applied for a minute or two. You can eat, drink and resume normal activity immediately unless told otherwise.
• Laboratory processing: the sample is centrifuged and analysed on an immunoassay platform. Reporting time depends on whether the assay runs in-house or is sent to a referral laboratory; ask your collection centre.

Total time in the facility is commonly 15-30 minutes, longer at busy times or if other tests and imaging are scheduled the same day.

Understanding your AFP report

AFP in adults is usually reported in ng/mL (equivalently 礸/L) with the laboratory's own reference interval printed alongside. Use the range on your own report, assay methods differ, and a value from one lab should not be read against another lab's range.

Points that help make sense of the number:

• Mildly raised AFP is common in chronic liver disease without cancer, especially during a hepatitis flare or active liver regeneration.
• A stable mildly raised value over time is interpreted differently from a value that is climbing steadily. Serial trend is often more informative than a single reading.
• A markedly raised AFP in someone with cirrhosis and a liver mass is clinically significant and triggers prompt specialist imaging, but even then, diagnosis rests on imaging characteristics, and sometimes biopsy.
• In germ cell tumours, AFP is interpreted with beta-hCG and LDH, and post-treatment decline is assessed against the expected half-life of the marker.
• In pregnancy, the report gives a risk estimate (for example 1 in 1,200) rather than a yes or no. "Screen positive" means further assessment is advised, not that a condition is present. Most women with a screen-positive result go on to have a normal detailed scan.

No AFP value diagnoses a disease on its own. The doctor who requested the test will interpret it with your history, examination, imaging and other laboratory results. Results vary depending on individual clinical circumstances.

When AFP results can be misleading

Causes of a falsely raised or non-cancer-raised AFP

• Pregnancy: physiologically high; an AFP intended as a tumour marker is uninterpretable in pregnancy.
• Acute or chronic hepatitis, including hepatitis B, C and E, and hepatitis flares.
• Cirrhosis and liver regeneration after injury.
• Drug-induced liver injury, including anti-tubercular therapy, and injury linked to some herbal, AYUSH or gym supplement products.
• Infancy: naturally high in newborns.
• Hereditary persistence of AFP, a benign familial trait.
• Assay interference: heterophile antibodies, high-dose biotin, or occasionally gross haemolysis or lipaemia of the sample.
• In pregnancy specifically: underestimated gestational age (baby further along than assumed), twins or higher-order multiples, fetal demise, or feto-maternal bleeding.

Causes of a falsely lowered or misleadingly normal AFP

• AFP-non-secreting tumours: many hepatocellular carcinomas, pure seminoma, pure dysgerminoma.
• Small tumour burden: early lesions frequently produce AFP levels within the reference range.
• Recent treatment: surgery, chemotherapy or ablation lowers AFP; a normal value soon after treatment does not confirm complete clearance.
• Very high concentrations can occasionally cause assay "hook effect" and a spuriously low reading; the laboratory rechecks on dilution if suspected.
• In pregnancy: overestimated gestational age, higher maternal weight (dilutional), and closed neural tube defects, which typically do not leak AFP.

Risks and safety

The blood draw itself

Venepuncture is a low-risk procedure. Possible effects include brief pain, bruising, light-headedness or fainting, and rarely a small haematoma or local infection. Bruising is more likely if you take anticoagulants or antiplatelet medicines. Tell the phlebotomist if you have fainted before or have lymphoedema or a dialysis fistula in one arm.

Risks of the downstream pathway

The more meaningful risks of the AFP test are indirect: a raised value can lead to further imaging with contrast or radiation, and in pregnancy a screen-positive result may lead to an invasive diagnostic test that carries its own small procedure-related risk. Anxiety from a borderline marker is real and common. A normal result can also cause false reassurance and delay. Discussing beforehand what will be done with each possible outcome reduces both problems.

Special situations

Pregnancy

AFP in pregnancy is a screening test that estimates risk and depends heavily on correct dating. Any ultrasound performed in pregnancy in India is governed by the PC-PNDT Act, 1994; fetal sex determination is prohibited, and registered facilities require the prescribed consent documentation. Genetic counselling should accompany any screen-positive result so that you can make an informed choice about further testing.

Children and newborns

AFP is used in paediatrics mainly for hepatoblastoma and germ cell tumours. Because normal values fall steeply over infancy, results need age-specific interpretation by a paediatric specialist.

People with chronic hepatitis B or C, or cirrhosis

Surveillance is generally imaging-based with AFP as an adjunct, at intervals set by your hepatologist. Skipping the ultrasound because AFP was normal is a common and risky mistake.

Chronic kidney disease and heart failure

These conditions do not alter how the AFP blood draw is done, but they influence the safety of any follow-on contrast imaging. Tell the radiology team about your kidney function and any fluid restriction before contrast studies are booked.

Diabetes on glucose-lowering therapy

Relevant only if fasting has been advised for companion tests. Speak to your prescriber about timing rather than skipping doses on your own.

People on treatment for cancer

AFP is measured on a schedule tied to treatment cycles and marker half-life. Ad hoc testing between planned time points often produces confusing numbers.

The AFP test in the Indian context

• Chronic hepatitis B and C remain important causes of cirrhosis and liver cancer in India, and much AFP testing happens within hepatitis follow-up clinics.
• Steatotic liver disease (SLD): the current umbrella term, with MASLD replacing NAFLD, MASH replacing NASH, and MetALD describing combined metabolic and alcohol-related disease, is an increasingly recognised route to cirrhosis in India, including in people with a lower BMI, since South Asians develop metabolic disease at lower body mass indices.
• Hepatitis E is a common cause of acute hepatitis in India and can transiently raise liver enzymes and AFP during recovery.
• Anti-tubercular therapy hepatotoxicity is a familiar clinical scenario; AFP may rise modestly during liver injury and regeneration.
• Herbal, AYUSH and gym supplement-related liver injury is under-reported. Always disclose these products.
• Terminology in Indian practice: patients are usually told "LFT" (SGPT/SGOT), "USG abdomen" or "sonography", and AFP is often described simply as a "liver cancer marker", a loose label worth clarifying with your doctor.
• Data protection: personal health data collected through hospital forms and portals is handled under the Digital Personal Data Protection Act, 2023.
• Advertising of diagnostic or curative claims is restricted under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, and doctors' conduct is governed by NMC regulations.

Cost and insurance in India

A standalone serum AFP test is a routine immunoassay and is generally priced in the low hundreds to low thousands of rupees across Indian laboratories. Prenatal serum screening panels that include AFP, and specialised markers such as AFP-L3 or DCP, cost more. Prices differ substantially between cities, laboratory tiers and hospital categories, so obtain a written quote from the facility.

Factors that affect what you pay:

• Standalone test versus panel: AFP bundled into a tumour marker panel or prenatal screen costs more than AFP alone.
• Assay platform and accreditation of the laboratory.
• In-house testing versus outsourcing to a referral laboratory.
• Urgency: expedited or after-hours processing may attract a surcharge.
• Home collection convenience charges.
• Setting: outpatient laboratory, corporate hospital or inpatient billing differ.
• City and market tier.

Insurance behaviour: outpatient diagnostic tests are often not reimbursed unless your policy includes an OPD or diagnostic benefit. The same test done during an admissible hospital admission, or as part of an approved cancer treatment pathway, is more commonly covered. Government schemes and state health insurance may cover investigations within a defined package. Confirm with your insurer or the hospital's TPA desk before testing.

Myths and facts

Frequently asked questions

Do I need to fast before an AFP test?

Fasting is usually not required for AFP alone. If AFP is grouped with fasting investigations such as glucose or lipids, the fasting instruction for those tests applies. Preparation rules are set by the collecting unit, so follow the instruction slip you were given rather than general advice.

How long does the whole process take?

The blood draw itself typically takes 2-5 minutes, and most people are in and out of the collection centre within 15 to 30 minutes including registration. Laboratory reporting time depends on whether the assay runs on site or is sent to a referral laboratory, ask your collection centre for their schedule.

Can the AFP test detect liver cancer early?

Only partly. A meaningful proportion of hepatocellular carcinomas, especially small ones, produce little or no AFP. That is why surveillance in people with cirrhosis or chronic hepatitis B or C is built around regular ultrasound, with AFP as a supporting test rather than a substitute.

My AFP is slightly above the reference range. Should I panic?

No. Mild elevations are common in chronic liver disease, during hepatitis flares and in liver regeneration. What matters is your clinical context, your imaging, and whether the value is stable or rising across repeat tests. Take the report to the doctor who ordered it for interpretation.

How is AFP different from beta-hCG in testicular tumours?

Different tumour components produce different markers. AFP typically rises with yolk sac elements and many non-seminomatous tumours, while beta-hCG rises with choriocarcinoma and some seminomas. Pure seminoma often raises neither. The markers are ordered together, with LDH, to help classify and monitor the tumour.

Is AFP screening in pregnancy compulsory?

No. Second-trimester serum screening is offered, not mandated, and you may decline it. Its value depends on accurate dating and on your willingness to consider further testing if the risk estimate is high. Discuss with your obstetrician which screening pathway, first trimester, second trimester or NIPT, suits your situation.

Can medicines or supplements affect the result?

High-dose biotin supplements can interfere with some immunoassays, and products causing liver injury, including certain herbal, AYUSH and gym supplements, and anti-tubercular drugs, can raise AFP indirectly. Disclose everything you take. Do not stop any prescribed medicine for a test; speak to your prescriber first.

What happens if my AFP result is abnormal?

Next steps depend on why the test was done. In adults this usually means a repeat measurement to establish a trend plus dedicated liver or pelvic imaging. In pregnancy it means counselling and a detailed ultrasound, with diagnostic testing offered if indicated. Your doctor will explain the pathway that applies to you.

Can AFP be used to monitor treatment?

Yes, this is one of its stronger roles. In AFP-producing tumours, a fall after surgery or chemotherapy supports response, and a subsequent rise prompts re-imaging. Timing is matched to marker half-life and treatment cycles, so tests are booked to a plan rather than done randomly.

Sources

• American Association for the Study of Liver Diseases (AASLD), guidance on hepatocellular carcinoma surveillance and diagnosis
• European Association for the Study of the Liver (EASL), clinical practice guidelines on hepatocellular carcinoma
• National Comprehensive Cancer Network (NCCN), guidelines on testicular cancer and hepatobiliary cancers
• Rinella ME et al. Multi-society Delphi consensus statement on new fatty liver disease nomenclature, 2023 (MASLD, MASH, MetALD, steatotic liver disease)
• American College of Obstetricians and Gynecologists (ACOG), practice bulletins on prenatal screening for fetal chromosomal and structural abnormalities
• Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, Government of India
• Digital Personal Data Protection Act, 2023, Government of India